{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T00:51:47Z","timestamp":1792889507769,"version":"4.5.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2011,11,16]],"date-time":"2011-11-16T00:00:00Z","timestamp":1321401600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocrine"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1007\/s12020-011-9559-x","type":"journal-article","created":{"date-parts":[[2011,11,16]],"date-time":"2011-11-16T08:16:50Z","timestamp":1321431410000},"page":"320-326","source":"Crossref","is-referenced-by-count":51,"title":["Time course of Graves\u2019 ophthalmopathy after total thyroidectomy alone or followed by radioiodine therapy: a 2-year longitudinal study"],"prefix":"10.1007","volume":"41","author":[{"given":"Annamaria","family":"De Bellis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Conzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilda","family":"Cennamo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Pane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Bellastella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caterina","family":"Colella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Assunta Dello","family":"Iacovo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanda Amoresano","family":"Paglionico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio Agostino","family":"Sinisi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack R.","family":"Wall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Bizzarro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Bellastella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,11,16]]},"reference":[{"key":"9559_CR1","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1210\/er.2002-0020","volume":"24","author":"BS Prabhakar","year":"2003","unstructured":"B.S. Prabhakar, R.S. Bahn, T.J. Smith, Current perspective on the pathogenesis of Graves\u2019 disease and ophthalmopathy. Endocr. Rev. 24, 802\u2013835 (2003)","journal-title":"Endocr. Rev."},{"key":"9559_CR2","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1210\/jc.2010-2329","volume":"96","author":"L Bartalena","year":"2011","unstructured":"L. Bartalena, The dilemma of how to manage Graves\u2019 hyperthyrodism in patients with associated orbitopathy. J. Clin. Endocrinol. Metab. 96, 592\u2013599 (2011)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"9559_CR3","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1056\/NEJM199311113292007","volume":"329","author":"RS Bahn","year":"1993","unstructured":"R.S. Bahn, A.E. Heufelder, Pathogenesis of Graves\u2019ophthalmopathy. New Engl. J. Med. 329, 1468\u20131475 (1993)","journal-title":"New Engl. J. Med."},{"key":"9559_CR4","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/0140-6736(93)91475-2","volume":"342","author":"A Feliciello","year":"1993","unstructured":"A. Feliciello, A. Porcellini, I. Ciullo, G. Bonavolont\u00e0, E.V. Avvedimento, G. Fenzi, Expression of thyrotropin-receptor mRNA in healthy and Graves\u2019 disease retro-orbital tissue. Lancet 342, 337\u2013338 (1993)","journal-title":"Lancet"},{"key":"9559_CR5","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1046\/j.1365-2265.2003.01708.x","volume":"58","author":"IM Wakelkamp","year":"2003","unstructured":"I.M. Wakelkamp, O. Bakker, L. Baldeschi, W.M. Wiersinga, M.F. Prummel, TSH-R expression and cytokine profile in orbital tissue of active vs. inactive Graves\u2019 ophthalmopathy patients. Clin. Endocrinol. 58, 280\u2013287 (2003)","journal-title":"Clin. Endocrinol."},{"key":"9559_CR6","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1210\/jc.85.4.1641","volume":"85","author":"K Gunji","year":"2000","unstructured":"K. Gunji, A. De Bellis, A. Wu Li, M. Yamada, S. Kubota, B. Ackrell, S. Wengrowicz, A. Bellastella, A. Bizzarro, A. Sinisi, J.R. Wall, Cloning and characterization of the novel thyroid and eye muscle shared protein G2s: autoantibodies against G2s are closely associated with ophthalmopathy in patients with Graves\u2019 hyperthyroidism. J. Clin. Endocrinol. Metab. 85, 1641\u20131647 (2000)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"9559_CR7","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1089\/105072502753600115","volume":"12","author":"M Kaspar","year":"2002","unstructured":"M. Kaspar, C. Archibald, A. De Bellis, A. Wu Li, M. Yamada, C. Chang, G. Kahaly, J.R. Wall, Eye muscle antibodies and subtype of thyroid-associated ophthalmopathy. Thyroid 12, 187\u2013191 (2002)","journal-title":"Thyroid"},{"key":"9559_CR8","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/BF03345270","volume":"27","author":"T Mizokami","year":"2004","unstructured":"T. Mizokami, M. Salvi, J.R. Wall, Eye muscle antibodies in Graves\u2019 ophthalmopathy: pathogenic or secondary epiphenomenon? J. Endocrinol. Invest. 27, 221\u2013229 (2004)","journal-title":"J. Endocrinol. Invest."},{"key":"9559_CR9","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1210\/er.21.2.168","volume":"21","author":"L Bartalena","year":"2000","unstructured":"L. Bartalena, A. Pinchera, C. Marcocci, Management of Graves\u2019 ophthalmopathy: reality and perspectives. Endocr. Rev. 21, 168\u2013199 (2000)","journal-title":"Endocr. Rev."},{"key":"9559_CR10","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1210\/jc.2010-1424","volume":"96","author":"GJ Kahaly","year":"2011","unstructured":"G.J. Kahaly, O. Shimony, Y.N. Gellman, S.D. Lytton, L. Eshkar-Sebban, N. Rosenblum, E. Refaeli, S. Kassem, J. Ilany, D. Naor, Regulatory T-Cells in graves\u2019 orbitopathy: baseline findings and immunomodulation by Anti-T lymphocyte globulin. J. Clin. Endocrinol. Metab. 96, 422\u2013429 (2011)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"9559_CR11","first-page":"1108","volume":"114","author":"NA Patwardhan","year":"1993","unstructured":"N.A. Patwardhan, M. Moront, S. Rao, S. Rossi, L.E. Braverman, Surgery still has a role in Graves\u2019 hyperthyroidism. Surgery 114, 1108\u20131113 (1993)","journal-title":"Surgery"},{"key":"9559_CR12","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1046\/j.1445-2197.2002.02400.x","volume":"72","author":"MS Barakate","year":"2002","unstructured":"M.S. Barakate, G. Agarwal, T.S. Reeve, B. Barraclough, B. Robinson, L.W. Delbridge, Total thyroidectomy is now the preferred option for the surgical management of Graves\u2019 disease. ANZ J. Surg. 72, 321\u2013324 (2002)","journal-title":"ANZ J. Surg."},{"key":"9559_CR13","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1007\/BF03345279","volume":"27","author":"L Bartalena","year":"2004","unstructured":"L. Bartalena, M.L. Tanda, E. Piantanida, A. Lai, A. Pinchera, Relationship between management of hyperthyroidism and course of the ophthalmopathy. J. Endocrinol. Invest. 27, 288\u2013294 (2004)","journal-title":"J. Endocrinol. Invest."},{"key":"9559_CR14","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1007\/s002680010173","volume":"24","author":"RD Bliss","year":"2000","unstructured":"R.D. Bliss, P.G. Gauger, L.W. Delbridge, Surgeon\u2019s approach to the thyroid gland: surgical anatomy and the importance of technique. World J. Surg. 24, 891\u2013897 (2000)","journal-title":"World J. Surg."},{"key":"9559_CR15","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1111\/j.1365-2265.2008.03279.x","volume":"69","author":"SH Acharya","year":"2008","unstructured":"S.H. Acharya, A. Avenell, S. Philip, J. Burt, J.S. Bevan, P. Abraham, Radioiodine therapy (RAI) for Graves\u2019 disease (GD) and the effect on ophtalmopathy: a systematic review. Clin. Endocrinol. 69, 693\u2013950 (2008)","journal-title":"Clin. Endocrinol."},{"key":"9559_CR16","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1089\/thy.1992.2.235","volume":"2","author":"A Pinchera","year":"1992","unstructured":"A. Pinchera, W. Wiersinga, D. Glinoer, P. Kendall-Taylor, L. Koornneef, C. Marcocci, H. Schleusener, J. Romaldini, H. Niepominiscze, S. Nagataki, M. Izumi, Y. Inoue, J. Stockigt, J.R. Wall, F. Greenspan, D. Solomon, J. Garrity, C.A. Gorman, Classification of eye changes of Graves\u2019 disease. Thyroid 2, 235\u2013236 (1992)","journal-title":"Thyroid"},{"key":"9559_CR17","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1530\/eje.0.1480491","volume":"48","author":"MF Prummel","year":"2003","unstructured":"M.F. Prummel, A. Bakker, W.M. Wiersinga, L. Baldeschi, M.P. Mourits, P. Kendall-Taylor, P. Perros, C. Neoh, A.J. Dickinson, J.H. Lazarus, C.M. Lane, A.E. Heufelder, G.J. Kahaly, S. Pitz, J. Orgiazzi, A. Hullo, A. Pinchera, C. Marcocci, M.S. Sartini, R. Rocchi, M. Nardi, G.E. Krassas, A. Halkias, Multi-center study on the characteristics and treatment strategies of patients with Graves\u2019 orbitopathy: the first European group on Graves\u2019 orbitopathy experience. Eur. J. Endocrinol. 48, 491\u2013495 (2003)","journal-title":"Eur. J. Endocrinol."},{"key":"9559_CR18","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1089\/thy.2008.0034","volume":"18","author":"L Bartalena","year":"2008","unstructured":"L. Bartalena, L. Baldeschi, A.J. Dickinson, A. Eckstein, P. Kendall-Taylor, C. Marcocci, M.P. Mourits, P. Perros, K. Boboridis, A. Boschi, N. Curr\u00f2, C. Daumerie, G.J. Kahaly, G. Krassas, C.M. Lane, J.H. Lazarus, M. Marin\u00f2, M. Nardi, C. Neoh, J. Orgiazzi, S. Pearce, A. Pinchera, S. Pitz, M. Salvi, P. Sivelli, M. Stahl, G. von Arx, W.M. Wiersinga, Consensus statement of the European group on Graves\u2019 orbitopathy (EUGOGO) on management of Graves\u2019 orbitopathy. Thyroid 18, 281\u2013282 (2008)","journal-title":"Thyroid"},{"key":"9559_CR19","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1046\/j.1365-2265.1997.2331047.x","volume":"47","author":"MP Mourits","year":"1997","unstructured":"M.P. Mourits, M.F. Prummel, W.M. Wiersinga, L. Koornneef, Clinical activity score as a guide in the management of patients with Graves\u2019 ophthalmopathy. Clin. Endocrinol. 47, 9\u201314 (1997)","journal-title":"Clin. Endocrinol."},{"key":"9559_CR20","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1210\/jc.84.1.90","volume":"84","author":"S Costagliola","year":"1999","unstructured":"S. Costagliola, N.G. Morgenthaler, R. Hoermann, K. Badenhoop, J. Struck, D. Freitag, S. Poertl, W. Weglohner, J.M. Hollidt, B. Quadbeck, J.E. Dumont, P.M. Schumm-Draeger, A. Bergmann, K. Mann, G. Vassart, K.H. Usadel, Second generation assay for thyrotropin receptor antibodies has superior diagnostic sensitivity for Graves\u2019 disease. J. Clin. Endocrinol. Metab. 84, 90\u201397 (1999)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"9559_CR21","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1530\/eje.0.1320406","volume":"132","author":"B Winsa","year":"1995","unstructured":"B. Winsa, J. Rastad, G. Akerstrom, H. Johansson, K. Westermark, F.A. Karlsson, Retrospective evaluation of subtotal and total thyroidectomy in Graves\u2019 disease with and without endocrine ophthalmopathy. Eur. J. Endocrinol. 132, 406\u2013412 (1995)","journal-title":"Eur. J. Endocrinol."},{"key":"9559_CR22","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1007\/BF03347330","volume":"21","author":"AP Weetman","year":"1998","unstructured":"A.P. Weetman, B.J. Harrison, Ablative or non-ablative therapy for Graves\u2019 hyperthyroidism in patients with ophthalmopathy? J. Endocrinol. Invest. 21, 472\u2013475 (1998)","journal-title":"J. Endocrinol. Invest."},{"key":"9559_CR23","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1007\/BF03346411","volume":"31","author":"L Bartalena","year":"2008","unstructured":"L. Bartalena, C. Marcocci, A. Lai, M.L. Tanda, Graves\u2019 hyperthyroidism of recent onset and Graves\u2019 orbitopathy: to ablate or not to ablate the thyroid? J. Endocrinol. Invest. 31, 578\u2013581 (2008)","journal-title":"J. Endocrinol. Invest."},{"key":"9559_CR24","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1046\/j.1365-2265.1999.00843.x","volume":"51","author":"C Marcocci","year":"1999","unstructured":"C. Marcocci, G. Bruno-Bossio, L. Manetti, M.L. Tanda, P. Miccoli, P. Iacconi, M.P. Bartolomei, M. Nardi, A. Pinchera, L. Bartalena, The course of Graves\u2019 ophthalmopathy is not influenced by near total thyroidectomy: a case-control study. Clin. Endocrinol. 51, 503\u2013508 (1999)","journal-title":"Clin. Endocrinol."},{"key":"9559_CR25","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1089\/105072503322240004","volume":"13","author":"M Moleti","year":"2003","unstructured":"M. Moleti, F. Mattina, I. Salamone, M.A. Violi, C. Nucera, S. Baldari, M.G. Lo Schiavo, C. Regalbuto, F. Trimarchi, F. Vermiglio, Effects of thyroidectomy alone or followed by radioiodine ablation of thyroid remnants on the outcome of Graves\u2019 ophthalmopathy. Thyroid 13, 653\u2013658 (2003)","journal-title":"Thyroid"},{"key":"9559_CR26","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1089\/thy.1998.8.423","volume":"8","author":"P Perros","year":"1998","unstructured":"P. Perros, P. Kendall-Taylor, Natural history of thyroid eye disease. Thyroid 8, 423\u2013425 (1998)","journal-title":"Thyroid"},{"key":"9559_CR27","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1056\/NEJMcp0806317","volume":"360","author":"L Bartalena","year":"2009","unstructured":"L. Bartalena, M.L. Tanda, Clinical practice. Graves\u2019 ophthalmopathy. N. Engl. J. Med. 360, 994\u20131001 (2009)","journal-title":"N. Engl. J. Med."},{"key":"9559_CR28","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1365-2265.2006.02447.x","volume":"64","author":"A Antonelli","year":"2006","unstructured":"A. Antonelli, M. Rotondi, P. Fallahi, S.M. Ferrari, L. Barani, E. Ferranini, M. Serio, Increase of interferon-#-inducible CXC chemokine CXCL10 serum levels in patients with active Graves\u2019 disease, and modulation by methimazole therapy. Clin. Endocrinol. 64, 189\u2013195 (2006)","journal-title":"Clin. Endocrinol."},{"key":"9559_CR29","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1002\/bjs.5401","volume":"93","author":"A Antonelli","year":"2006","unstructured":"A. Antonelli, P. Fallahi, M. Rotondi, S.M. Ferrari, M. Serio, P. Miccoli, Serum levels of the interferon-gamma-inducible alpha chemokine CXCL10 in patients with active Graves\u2019 disease, and modulation by methimazole therapy and thyroidectomy. Br. J. Surg. 93, 1226\u20131231 (2006)","journal-title":"Br. J. Surg."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-011-9559-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12020-011-9559-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-011-9559-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T21:56:32Z","timestamp":1559426192000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12020-011-9559-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11,16]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["9559"],"URL":"https:\/\/doi.org\/10.1007\/s12020-011-9559-x","relation":{},"ISSN":["1355-008X","1559-0100"],"issn-type":[{"value":"1355-008X","type":"print"},{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,11,16]]}}}